#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thrombocytopenia Univentricular heart Pleomorphic leiomyosarcoma Adenocarcinoma gastric Cold type haemolytic anaemia Spinal cord injury Vernal keratoconjunctivitis Cytomegalovirus infection Spinal cord injury cervical Acute myeloid leukaemia refractory Primary myelofibrosis Colorectal cancer metastatic Haemophagocytic lymphohistiocytosis Neuroendocrine carcinoma Cholestatic pruritus More trials…

    Learn about Rare Diseases

    Small intestine leiomyosarcoma – Trials in Disease Cystic fibrosis – Treatment Propionic acidaemia – Basic Information Leiomyosarcoma recurrent – Basic Information Phenylketonuria Haemophagocytic lymphohistiocytosis – Life with Disease Piriformis syndrome – Treatment Undifferentiated sarcoma – Treatment Marginal zone lymphoma – Diagnostics Medulloblastoma recurrent More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Microcrystalline Cellulose Dicloxacillin Perindopril Arginine Lixisenatide Gsk4381562A Dorzolamide Hydrochloride ATUMELNANT Panobinostat Teprotumumab Avalglucosidase Alfa CARBACHOL Vanzacaftor Specific Nucleic Acid Sna-Veru Linrodostat Mesilate Retinol Palmitate Sqy51 Luspatercept Siltuximab 11902A Remifentanil More therapies…

    Learn about Your Condition

    Obstructive pancreatitis Optic glioma Salivary gland cancer Muscle spasticity Anal abscess Retroperitoneal cancer Procedural headache Lichen planus Fallopian tube cancer stage IV Renal cell carcinoma Epstein-Barr virus infection Basal cell carcinoma Diabetic retinopathy Vulvovaginal discomfort Behcet's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Jules Bordet

Institut Jules Bordet

Mijlenmeersstraat 90, Anderlecht, 1070, Belgium

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness of Triptorelin, Goserelin Acetate, and Enzalutamide in Patients with Oligorecurrent Hormone-Sensitive Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Degarelix
    • Enzalutamide
    • Goserelin Acetate
    Belgium Italy

  • Study on Using Indocyanine Green for Detecting Residual Disease in Head and Neck Cancer Surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Head and neck cancer
    Investigated Drugs:
    • Indocyanine Green
    Belgium France

  • Study on the Benefits of Autologous Stem Cell Transplantation for Patients with Peripheral T-cell Lymphoma Using Etoposide and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated Drugs:
    • Brentuximab Vedotin
    • Cyclophosphamide Monohydrate
    • Doxorubicin Hydrochloride
    Belgium France

  • Study on the Effect of Metastasis-Directed Therapy with Lutetium (177Lu) Zadavotide Guraxetan in Patients with Advanced Prostate Cancer and Up to 5 Progressive Lesions

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Abiraterone Acetate
    • Apalutamide
    • Cabazitaxel
    Belgium

  • Study Comparing Trastuzumab Deruxtecan with Standard Treatment for Patients with HER2-positive Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Aprepitant
    • Betamethasone
    • Carboplatin
    Belgium The Netherlands Norway Sweden

  • Study on Durvalumab for Patients with High-Risk Endometrial Cancer After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Durvalumab
    Belgium Czechia France Germany Italy The Netherlands

  • Study on Continuing Somatostatin Analogues with Sunitinib, Octreotide, and Lutetium (177Lu) Oxodotreotide for Patients with Neuroendocrine Tumors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastroenteropancreatic neuroendocrine tumour disease
    • Neuroendocrine tumour
    • Pancreatic neuroendocrine tumour
    Investigated Drugs:
    • Everolimus
    • Lanreotide
    • Lutetium (177Lu) Oxodotreotide
    Belgium The Netherlands

  • Study on Immune Markers for Checkpoint Inhibitor Toxicity in Cancer Patients Using Atezolizumab, Dexamethasone Sodium Phosphate, and Alizapride

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Alizapride
    • Atezolizumab
    • Avelumab
    Belgium

  • Long-Term Follow-Up Study for Patients Treated with Idecabtagene Vicleucel or Lisocabtagene Maraleucel for Cancer

    Recruiting

    4 1 1
    Investigated Drugs:
    • ARLOCABTAGENE AUTOLEUCEL
    • CC-97540
    • Idecabtagene Vicleucel
    Austria Belgium Czechia Denmark Finland France +11

  • Study of Sacituzumab Govitecan and Pembrolizumab for Patients with Triple Negative Breast Cancer with Residual Disease After Surgery and Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Capecitabine
    • Pembrolizumab
    • Sacituzumab Govitecan
    Belgium France Germany Ireland Italy Spain
Previous Page
1 … 7 8 9 10 11 … 22
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!